Go Back   ITalkCash.com - Forum for financial investments > Public Investment > Penny Stocks
Forum Register Calendar Search Today's Posts Mark Forums Read

Pbli - penny stocks

Reply
 
LinkBack Thread Tools Display Modes
Old 01-11-2010, 10:02 AM
ItalkCash User
 
Join Date: Oct 2009
Posts: 524
Default Pbli

.Proton Laboratories, Inc. Announces the Acquisition of Regenobody S.A.

Buzz up! 0 Print..Companies:Proton Laboratories.Related Quotes
Symbol Price Change
PLBI.PK 0.01 0.00


{"s" : "plbi.pk","k" : "c10,l10,p20,t10","o" : "","j" : ""} Press Release Source: Proton Laboratories, Inc. On Friday January 8, 2010, 2:25 pm EST

SOSUA BAY, Dominican Republic, Jan. 8, 2010 (GLOBE NEWSWIRE) -- Proton Laboratories, Inc. (Pink Sheets:PLBI - News), a Washington corporation, today announced the acquisition of Regenobody S.A., a Dominican Republic company involved in some of the latest technologies associated with stem cell regeneration using the patient's own stem cells. Pursuant to the Agreement, the Company (PLBI) will issue 300,000,000 of its common shares to the Regenobody shareholders, which will result in the shareholders of Regenobody acquiring shareholder control of Proton Laboratories, Inc.



Armando Casciati, newly elected President of Proton Laboratories, Inc. stated that the new company will aggressively work toward completing the development of its laboratory and acquisition of the balance of the needed equipment from its Korean licensor and patent holder, RNLBIO. It is anticipated that a name change and symbol change will occur in the next 90 days. The prior Proton directors have resigned concurrent with the acquisition. More information may be seen at the Company's website Stem Cell Therapy | Regenobody Stem Cells Treatment Clinic | Dominican Republic Stem Cells Clinic.



The statements made in this release contain certain forward-looking statements concerning potential developments affecting the business, prospects, financial conditions and other aspects of the company to which this release pertains. The actual results of specific items described in this release, and the company's operations generally, may differ materially from what is projected in such forward-looking statements. Although the statements are based upon the best judgments of management of the company as of the date of this release, significant deviation in magnitude, timing and other factors may result from business risks and uncertainties including without limitation, the company's dependence on third parties, market conditions, technical factors, the availability of outside capital and receipt of revenues, and other factors, many of which are beyond the control of the Company
Reply With Quote
Old 01-11-2010, 10:35 AM
ItalkCash User
 
Join Date: Oct 2009
Posts: 127
Default

PLBI back into play again. Imo this one is going to be huge again!!! This is a definate bounce back for this company. I have looked at the charts on this one and there is no resistance on this one till .16 It is time to load up and swing trade this one!!! Good luck to all!!!
Reply With Quote
Old 01-11-2010, 05:12 PM
ItalkCash User
 
Join Date: Oct 2009
Posts: 524
Default Plbi

PLBI
+132% hit a high of 200% volume exploded,
Seen price appreciation right from the bell
Moving on the offer @ .023
Hit the 52 week high @.03
Days range .0125 X .030 Keep your eye on it
I believe we will see another late afternoon rally that could push over .0003
All charts are indicate this could be strong play through out the week
Reply With Quote
Old 01-12-2010, 02:30 PM
ItalkCash User
 
Join Date: Oct 2009
Posts: 524
Default Plbi

Regenobody S.A. Obtains License From the Dominican Republic to Harvest, Incubate, and Transplant Stem Cells

Buzz up! 0 Print..Press Release Source: Proton Laboratories, Inc. On Tuesday January 12, 2010, 10:14 am

SOSUA BAY, Dominican Republic, Jan. 12, 2010 (GLOBE NEWSWIRE) -- Proton Laboratories, Inc. (Pink Sheets:PLBI - News), through the newly acquired Regenobody S.A, has obtained a license, through LifeXtension Worldwide, from the Government of the Dominican Republic for harvesting, incubating, and transplanting stems cells.



Armando Casciati, President of Proton Laboratories, Inc., stated; "This is tremendous news for our company. Very rarely are companies licensed by their respective governments to conduct research, harvest, and incubate stems cells while then being able to transplant these cells back to the patients for therapeutic benefit." Regenobody S.A. will be utilizing procedures and equipment obtained through an EXCLUSIVE Caribbean license from its Korean licensor and patent holder, RNL BIO Co. Ltd. Prior to Regenobody S.A. obtaining the EXCLUSIVE Caribbean licensing rights, these procedures were only available in Japan, Korea, and China. More information may be seen at the Company's website Stem Cell Therapy | Regenobody Stem Cells Treatment Clinic | Dominican Republic Stem Cells Clinic. Mr. Casciati went on to state that; "We are focused on developing a world class facility with world class equipment, technicians and procedures to allow patients the ability to utilize their own stem cells, mainly obtained through the fatty tissues of the stomach, to improve their lives."



The statements made in this release contain certain forward-looking statements concerning potential developments affecting the business, prospects, financial conditions and other aspects of the company to which this release pertains. The actual results of specific items described in this release, and the company's operations generally, may differ materially from what is projected in such forward-looking statements. Although the statements are based upon the best judgments of management of the company as of the date of this release, significant deviation in magnitude, timing and other factors may result from business risks and uncertainties including without limitation, the company's dependence on third parties, market conditions, technical factors, the availability of outside capital and receipt of revenues, and other factors, many of which are beyond the control of the Company.






Contact:
Reply With Quote
Old 04-16-2010, 07:07 PM
ItalkCash User
 
Join Date: Oct 2009
Posts: 127
Default Plbi

PLBI, Here is one to watch. Stock is trading like news is coming. It is three times the ten day and is +20% today so far. There has been a little chatter about this stock having a run again next week. I have looked at the charts on this one and there is very weak resistace holding this one back and we are already above the 20, 50 and 200 day MA. We coulld see some nice gains on this one. Remember to do your own dd. Good luck to you all
Reply With Quote
Old 04-22-2010, 11:39 AM
ItalkCash User
 
Join Date: Nov 2009
Posts: 87
Default Plbi

PLBI proton labs. inc, is a standout stock imo, recently announced that they will have an acquisition of regenobody S.A a company in the Dominican Republic highly involved in the lasted technological breakthroughs in Stem cell regeneration using patients own cells.
Pursuant to the Agreement, the Company (PLBI) will issue 300,000,000 of its common shares to the Regenobody shareholders, which will result in the shareholders of Regenobody acquiring shareholder control of Proton Laboratories, Inc.
aggressively work toward completing the development of its laboratory and acquisition of the balance of the needed equipment from its Korean licensor and patent holder, RNLBIO. It is anticipated that a name change and symbol change will occur in the next 90 days. It's been a little over 90 days and imo, something should be shaping up very soon. Well, i honestly think PLBI is set up for a run. test indicators Bollinger bands expanding, may see some volatility spiking with some price shifting. SAR reversal ind. @ .0196 and descending. currently testing .015 range cud see a big force play if reversal fills.
Reply With Quote
Old 04-30-2010, 03:27 PM
ItalkCash User
 
Join Date: Dec 2009
Posts: 82
Default Plbi

PLBI/RegenoBody Announces Filing of Additional Information on OTC Markets.com…
PLBI NEWS
PLBI, Proton Laboratories, Inc., recently announced the acquisition of Regenobody S.A., a Dominican Republic company involved in some of the latest technologies associated with stem cell regeneration using the patient's own stem cells regeneration.

Stem cell research is a revolutionary Multi-Billion dollar business used to treat, multiple sclerosis, muscular dystrophy, Parkinson’s , Diabetes, Cancer, heart disease, strokes, Spinal injuries, kidney diseases, various types of Arthritis and anti-aging solutions.

Other companies in this sector include Amstem Corporation AMST .., Pro-pharmaceuticals, BioSpecifics Tech. corp., Durect Corporations and International Stem Cell Corp – ISCO
Reply With Quote
Old 05-03-2010, 01:30 PM
ItalkCash User
 
Join Date: Dec 2009
Posts: 82
Default Plbi

PLBI-REGENOBODY S.A., a wholly owned subsidiary of Proton Laboratories, Inc., brings the benefits of bioscience to patients who have been diagnosed with chronic debilitating diseases, offering viable, efficient therapeutic options with special Stem Cell Therapies utilizing the most potent cells in the world, today. Therapies are tailored for each individual, based upon their specific needs. Cells are obtained by the most modern technologic method. Their transplant physicians and stem cell laboratory scientists, in conjunction with RNL Bio, have been regarded as the best in the world. Stem cells derived from Autologous (Stem cells taken from your own body) and Allogeneic (Stem cells from a source other than your own) are used depending on the particular condition that needs to be treated. Treatments are delivered by an experienced team of International and U.S. Board Certified Physicians who are guided by strict protocols ensuring excellence in medical care.
Reply With Quote
Old 05-05-2010, 02:57 PM
ItalkCash User
 
Join Date: Dec 2009
Posts: 82
Default Plbi

--------------------------------------------------------------------------------

PLBI - The next one to move into

REGENOBODY IS A WORLD LEADER IN STEM CELLS TREATMENTS

By applying the regenerative powers of stem cells, REGENOBODY AGE REVERSAL achieves the target of halting the ageing degenerative process, improving the quality of life of people willing to maintain a young look and a real rejuvenation in the inside, with better functioning, re-energized and healthy organs.


REGENOBODY THERAPEUTIC brings the benefits of bioscience to patients who have been diagnosed with chronic debilitating diseases, offering viable, efficient therapeutic options.


Many different conditions can be successfully addressed using their special Stem Cell Therapies. Their institute utilizes the most potent cells in the world, today. Therapies are tailored for each individual, based upon their specific needs. Cells
Reply With Quote
Old 05-05-2010, 05:58 PM
ItalkCash User
 
Join Date: Dec 2009
Posts: 82
Default Plbi

PROTON LABORATORIES, INC. (PLBI)
Proton Laboratories, Inc., through the acquisition of Regenobody S.A., a Dominican Republic company, is involved in some of the latest technologies associated with stem cell regeneration using the patient's own stem cells.
Recent Price Last
0.01
Market Capitalization $1.08M
Est Float 36M
Outstanding Shares 56M
Quotation OTC.PK

Proton Laboratories, Inc.

1135 Atlantic Avenue
Alameda, CA 94501



Phone: 888-548-3002
Fax: 888-548-3004
Stem Cell Therapy | Regenobody Stem Cells Treatment Clinic | Dominican Republic Stem Cells Clinic Similar Companies in Sector

· Stem Cell Therapy International, Inc. is a development-stage company. The Company is engaged in the licensing of stem cell technology, the sale of stem cell products, and the referral of patients to affiliated stem cell clinics through its wholly-owned subsidiary Stem Cell Therapy International Corp. OTCBB:SCII Recent Price: $.112
· International Stem Cell Corporation, incorporated is a biotechnology company. The Company is focused on developing therapeutic products and research products. It is in development-stage. The Company’s objective is to create an unlimited source of human cells for use in the treatment of several diseases, including diabetes, liver disease, corneal disease, and retinal disease through cell transplant therapy. OTCBB: ISCO Recent Price: $.83
Reply With Quote
Reply

Thread Tools
Display Modes


Lotto Premium Bonds Book hotel room.



Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2012, vBulletin Solutions, Inc.
Search Engine Friendly URLs by vBSEO 3.6.0